Treatment of Chronic Venous Insufficiency in Adults with Symptomatic Accessory Great Saphenous Vein Reflux

Clinical scenario

This protocol addresses adult patients with chronic venous insufficiency (CVI) who have symptomatic accessory great saphenous vein (GSV) reflux — a specific subset of venous disease where the accessory great saphenous vein is the primary source of pathological reflux contributing to the patient's symptoms.

Patient population

Adults presenting with symptomatic accessory great saphenous vein reflux. SCAI guideline evidence supports a combined management approach for this population, distinguishing it from uncomplicated varicose vein disease without accessory GSV involvement.

Treatment approach (partial overview)

First-line management centers on conservative therapy, which forms the foundation of treatment for chronic venous disease in this setting. The full protocol specifies the components of conservative care and how they are structured for this patient group.

Complete regimen, sequencing, and evidence summary available via the full protocol →

Clinical goals

Reduced leg discomfort Reduced edema volume

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jscai.2025.103729

For patients with symptomatic accessory GSV reflux, the SCAI guideline panel suggests ablation therapy plus conservative management rather than conservative management alone (conditional recommendation, very low certainty of evidence).
The first line of treatment for CVD is conservative therapy, which generally includes compression therapy, venotonic medications, lifestyle changes, weight loss if applicable, and wound care for patients with ulcerative disease.
In patients with symptomatic varicose veins, compression may reduce discomfort (standard mean difference, 0.68; 95% CI, 0.87–0.49), which studies measured using a numerical rating scale from 0 or 1 (least pain) to 10 (most pain).

View source ↗